|
JP2884452B2
(ja)
|
1991-10-09 |
1999-04-19 |
清水建設株式会社 |
セグメントを利用した立坑構築工法
|
|
LT1993360T
(lt)
|
2005-12-28 |
2017-06-12 |
Vertex Pharmaceuticals Incorporated |
N-[2,4-bis(1,1-dimetiletil)-5-hidroksifenil]-1,4-dihidro-4-oksochinolin-3-karboksamido kieta forma
|
|
BRPI0906473A8
(pt)
|
2008-01-04 |
2016-02-10 |
Intellikine Inc |
Certas entidades químicas, composições e métodos
|
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
|
JP5801197B2
(ja)
|
2008-09-03 |
2015-10-28 |
ノノ インコーポレイテッド |
痛みの治療に関する薬剤及び方法
|
|
JP5848712B2
(ja)
|
2009-12-11 |
2016-01-27 |
ノノ インコーポレイテッド |
虚血性疾患および他の疾患を治療するための薬剤および方法
|
|
JP5951600B2
(ja)
|
2010-05-21 |
2016-07-13 |
インフィニティー ファーマシューティカルズ， インコーポレイテッド |
キナーゼ調節のための、化合物、組成物および方法
|
|
AU2011202542A1
(en)
*
|
2010-07-14 |
2012-02-02 |
Indian Institute Of Science |
Benzothiophene carboxamide compounds, composition and applications thereof
|
|
US9255074B2
(en)
|
2010-07-16 |
2016-02-09 |
Abbvie Inc. |
Process for preparing antiviral compounds
|
|
NZ705225A
(en)
|
2010-07-16 |
2016-11-25 |
Abbvie Bahamas Ltd |
Process for preparing antiviral compounds
|
|
US8841487B2
(en)
|
2010-07-16 |
2014-09-23 |
Abbvie Inc. |
Phosphine ligands for catalytic reactions
|
|
US8975443B2
(en)
|
2010-07-16 |
2015-03-10 |
Abbvie Inc. |
Phosphine ligands for catalytic reactions
|
|
CN103201279A
(zh)
|
2010-11-05 |
2013-07-10 |
赛诺米克斯公司 |
作为trpm8的调节剂有用的化合物
|
|
WO2012071369A2
(en)
|
2010-11-24 |
2012-05-31 |
The Trustees Of Columbia University In The City Of New York |
A non-retinoid rbp4 antagonist for treatment of age-related macular degeneration and stargardt disease
|
|
EP3238722B1
(en)
|
2011-01-10 |
2019-03-13 |
Infinity Pharmaceuticals, Inc. |
Solid forms of isoquinolinones
|
|
US9334256B2
(en)
|
2011-06-15 |
2016-05-10 |
Nono Inc. |
Agents and methods for treating ischemic and other diseases
|
|
US9056877B2
(en)
|
2011-07-19 |
2015-06-16 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
KR20130016041A
(ko)
*
|
2011-08-04 |
2013-02-14 |
재단법인 의약바이오컨버젼스연구단 |
신규한 아닐린 유도체 및 이의 용도
|
|
PE20141371A1
(es)
|
2011-08-29 |
2014-10-13 |
Infinity Pharmaceuticals Inc |
Compuestos heterociclicos y usos de los mismos
|
|
EP2811990B1
(en)
*
|
2012-02-10 |
2017-10-25 |
The Board of Regents of The University of Texas System |
Modulators of exchange proteins directly activated by camp (epacs)
|
|
EP2831071B1
(en)
*
|
2012-03-29 |
2018-11-14 |
Merck Sharp & Dohme Corp. |
Imidazolyl methyl piperidine t-type calcium channel antagonists
|
|
US9333202B2
(en)
|
2012-05-01 |
2016-05-10 |
The Trustees Of Columbia University In The City Of New York |
Non-retinoid antagonists for treatment of age-related macular degeneration and stargardt disease
|
|
US8828998B2
(en)
|
2012-06-25 |
2014-09-09 |
Infinity Pharmaceuticals, Inc. |
Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
|
|
CN103570705B
(zh)
*
|
2012-07-18 |
2017-01-25 |
中国医学科学院医药生物技术研究所 |
取代的n‑((1＇,3＇‑杂唑‑4＇‑基)‑甲基)‑4‑苯甲酰基六氢吡啶类化合物及其用途
|
|
BR112015004666B1
(pt)
|
2012-09-07 |
2022-04-26 |
Novartis Ag |
Derivados de indol carboxamida, seu uso, e composição farmacêutica
|
|
BR102012024778A2
(pt)
*
|
2012-09-28 |
2014-08-19 |
Cristalia Prod Quimicos Farm |
Compostos heteroaromáticos; processo para preparar os compostos, composições farmacêuticas, usos e método de tratamento para as dores aguda e crônica
|
|
RU2702908C2
(ru)
|
2012-11-01 |
2019-10-14 |
Инфинити Фармасьютикалз, Инк. |
Лечение злокачественных опухолей с использованием модуляторов изоформ pi3-киназы
|
|
EP2733146A1
(en)
*
|
2012-11-20 |
2014-05-21 |
KTB Tumorforschungsgesellschaft mbH |
Thioether derivatives as protein kinase inhibitors
|
|
US9925193B2
(en)
|
2012-11-20 |
2018-03-27 |
Proqinase Gmbh |
Thioether derivatives as protein kinase inhibitors
|
|
CA2899124A1
(en)
|
2013-01-25 |
2014-07-31 |
Glaxosmithkline Intellectual Property Development Limited |
Compounds
|
|
EP3495359A1
(en)
*
|
2013-02-04 |
2019-06-12 |
Janssen Pharmaceutica NV |
Flap modulators
|
|
TWI644899B
(zh)
|
2013-02-04 |
2018-12-21 |
健生藥品公司 |
Ｆｌａｐ調節劑
|
|
US10273243B2
(en)
|
2013-03-14 |
2019-04-30 |
The Trustees Of Columbia University In The City Of New York |
4-phenylpiperidines, their preparation and use
|
|
US9938291B2
(en)
|
2013-03-14 |
2018-04-10 |
The Trustess Of Columbia University In The City Of New York |
N-alkyl-2-phenoxyethanamines, their preparation and use
|
|
EP2968303B1
(en)
|
2013-03-14 |
2018-07-04 |
The Trustees of Columbia University in the City of New York |
Octahydrocyclopentapyrroles, their preparation and use
|
|
US9944644B2
(en)
|
2013-03-14 |
2018-04-17 |
The Trustees Of Columbia University In The City Of New York |
Octahydropyrrolopyrroles their preparation and use
|
|
US9481667B2
(en)
|
2013-03-15 |
2016-11-01 |
Infinity Pharmaceuticals, Inc. |
Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
|
|
WO2015039333A1
(en)
*
|
2013-09-22 |
2015-03-26 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
|
|
CN105829297B
(zh)
*
|
2013-12-20 |
2019-08-09 |
埃斯蒂文制药股份有限公司 |
具有抗疼痛的多重模式活性的哌啶化合物
|
|
ES2796090T3
(es)
|
2014-02-10 |
2020-11-25 |
Inst Curie |
Uso de moduladores MCOLN-1 para regular la migración celular
|
|
WO2015160975A2
(en)
|
2014-04-16 |
2015-10-22 |
Infinity Pharmaceuticals, Inc. |
Combination therapies
|
|
CN111393434B
(zh)
|
2014-04-30 |
2022-11-04 |
哥伦比亚大学董事会 |
取代的4-苯基哌啶及其制备和用途
|
|
WO2016049774A1
(en)
*
|
2014-10-03 |
2016-04-07 |
The Royal Institution For The Advancement Of Learning/Mcgill University |
Urea and bis-urea based compounds and analogues thereof useful in the treatment of androgen receptor mediated diseases or disorders
|
|
CA2963945C
(en)
|
2014-10-07 |
2023-01-10 |
Vertex Pharmaceuticals Incorporated |
Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator
|
|
JP6588027B2
(ja)
|
2014-10-24 |
2019-10-09 |
武田薬品工業株式会社 |
複素環化合物
|
|
WO2016077793A1
(en)
*
|
2014-11-14 |
2016-05-19 |
Children's Hospital Medical Center |
Sos1 inhibitors for cancer treatment
|
|
SG11201606876RA
(en)
|
2015-03-04 |
2016-10-28 |
Gilead Sciences Inc |
Toll like receptor modulator compounds
|
|
US9737512B2
(en)
|
2015-03-11 |
2017-08-22 |
The Board Of Regents Of The University Of Texas System |
Methods and compositions for treating chronic pain
|
|
WO2017007755A1
(en)
|
2015-07-06 |
2017-01-12 |
Rodin Therapeutics, Inc. |
Heterobicyclic n-aminophenyl-amides as inhibitors of histone deacetylase
|
|
HUE057041T2
(hu)
|
2015-07-06 |
2022-04-28 |
Alkermes Inc |
Hiszton deacetiláz hetero-halogén gátlói
|
|
BR112018006471B1
(pt)
|
2015-10-01 |
2024-02-27 |
Senomyx, Inc |
Composto, composição, método de modular o membro de melastina do canal potencial do receptor transitório 8 (trpm8), método de modular a sensação de resfrescância de uma composição e método de induzir uma sensação de refrescância em um ser humano ou animal
|
|
PL3388420T3
(pl)
*
|
2015-12-07 |
2022-12-05 |
Hinova Pharmaceuticals Inc. |
Związki chinolinowe, sposób ich wytwarzania i ich zastosowanie jako leku stanowiącego inhibitor transportera anionu kwasu moczowego
|
|
EP3474856B1
(en)
|
2016-06-24 |
2022-09-14 |
Infinity Pharmaceuticals, Inc. |
Combination therapies
|
|
SI3507276T1
(sl)
|
2016-09-02 |
2022-01-31 |
Gilead Sciences, Inc. |
Spojine modulatorja toličnih receptorjev
|
|
WO2018045150A1
(en)
|
2016-09-02 |
2018-03-08 |
Gilead Sciences, Inc. |
4,6-diamino-pyrido[3,2-d]pyrimidine derivaties as toll like receptor modulators
|
|
US10722489B2
(en)
*
|
2016-10-31 |
2020-07-28 |
Peking University |
D-3-phosphoglycerate dehydrogenase allosteric inhibitor and use thereof
|
|
CN106565643A
(zh)
*
|
2016-10-31 |
2017-04-19 |
北京大学 |
D‑3‑磷酸甘油酸脱氢酶别构抑制剂及其应用
|
|
HRP20220223T1
(hr)
|
2017-01-11 |
2022-04-29 |
Alkermes, Inc. |
Biciklički inhibitori histon deacetilaze
|
|
CN106822897B
(zh)
*
|
2017-02-17 |
2018-10-19 |
河北盛华尔生物医疗科技有限公司 |
靶向下调trpm7基因表达在提高肺鳞癌化疗敏感性方面的应用
|
|
EP3601274A1
(en)
*
|
2017-03-31 |
2020-02-05 |
Perenna Pharmaceuticals, Inc. |
Compounds useful as inhibitors of alcat 1
|
|
US11389444B2
(en)
|
2017-06-15 |
2022-07-19 |
Belite Bio, Inc |
Methods of treating metabolic diseases with fused bicyclic pyrazoles
|
|
TWI848911B
(zh)
|
2017-06-15 |
2024-07-21 |
美國哥倫比亞大學紐約市信託會 |
以三唑并吡啶治療rbp4相關疾病之方法
|
|
WO2018232160A1
(en)
*
|
2017-06-15 |
2018-12-20 |
Belite Bio, Inc |
Methods of treating metabolic diseases with phenoxyethylamides
|
|
US11225475B2
(en)
|
2017-08-07 |
2022-01-18 |
Alkermes, Inc. |
Substituted pyridines as inhibitors of histone deacetylase
|
|
PY19106549A
(es)
*
|
2018-12-21 |
2021-07-13 |
Bayer Ag |
1,3,4-oxadiazoles y derivados de éstos como nuevos agentes fungicidas
|
|
TWI751517B
(zh)
|
2019-04-17 |
2022-01-01 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
|
TW202210480A
(zh)
|
2019-04-17 |
2022-03-16 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
|
TWI879779B
(zh)
|
2019-06-28 |
2025-04-11 |
美商基利科學股份有限公司 |
類鐸受體調節劑化合物的製備方法
|
|
CN114364382A
(zh)
|
2019-07-08 |
2022-04-15 |
倍亮生物有限责任公司 |
Rbp4抑制剂的制剂和使用方法
|
|
WO2021138540A1
(en)
|
2020-01-03 |
2021-07-08 |
Berg Llc |
Polycyclic amides as ube2k modulators for treating cancer
|
|
WO2021257857A1
(en)
|
2020-06-19 |
2021-12-23 |
Incyte Corporation |
Naphthyridinone compounds as jak2 v617f inhibitors
|
|
WO2021257863A1
(en)
|
2020-06-19 |
2021-12-23 |
Incyte Corporation |
Pyrrolotriazine compounds as jak2 v617f inhibitors
|
|
US11767323B2
(en)
|
2020-07-02 |
2023-09-26 |
Incyte Corporation |
Tricyclic pyridone compounds as JAK2 V617F inhibitors
|
|
IL299612A
(en)
|
2020-07-02 |
2023-03-01 |
Incyte Corp |
Tricyclic urea compounds as JAK2 V617F inhibitors
|
|
US11661422B2
(en)
|
2020-08-27 |
2023-05-30 |
Incyte Corporation |
Tricyclic urea compounds as JAK2 V617F inhibitors
|
|
EP4255893A4
(en)
*
|
2020-12-04 |
2025-04-23 |
The Johns Hopkins University |
COMPOUNDS AND THEIR USE FOR THE TREATMENT OF NEUROPATHIC PAIN
|
|
US11919908B2
(en)
|
2020-12-21 |
2024-03-05 |
Incyte Corporation |
Substituted pyrrolo[2,3-d]pyrimidine compounds as JAK2 V617F inhibitors
|
|
WO2022148781A1
(en)
|
2021-01-05 |
2022-07-14 |
Institut Curie |
Combination of mcoln activators and immune checkpoint inhibitors
|
|
CA3211748A1
(en)
|
2021-02-25 |
2022-09-01 |
Incyte Corporation |
Spirocyclic lactams as jak2 v617f inhibitors
|
|
KR102905373B1
(ko)
*
|
2021-04-08 |
2025-12-29 |
주식회사 종근당 |
히스톤 탈아세틸화효소 6 억제제로서의 1,3,4-옥사다이아졸 싸이오카보닐 화합물 및 이를 포함하는 약제학적 조성물
|
|
CN114685371A
(zh)
*
|
2022-03-08 |
2022-07-01 |
四川大学 |
吡唑甲酰胺衍生物及其制备方法和用途
|
|
IL315647A
(en)
|
2022-03-17 |
2024-11-01 |
Incyte Corp |
Tricyclic urea compounds as Jak2 and 617f inhibitors
|
|
US20260085073A1
(en)
*
|
2022-09-12 |
2026-03-26 |
Hotspot Therapeutics, Inc. |
Pyrazolylcarboxamide compounds and their use in therapy
|
|
CN121930167B
(zh)
*
|
2026-03-30 |
2026-07-17 |
山东国际生物科技园发展有限公司 |
一种杀粉蝶霉素类化合物及其在抗肿瘤药物制备中的应用
|